【Ho Chi Minh 】Guangli Biotechnology Group Partners with Juxing Medical to Enter Vietnam’s Beauty Market – Industry

Guangli Biotechnology Holdings (6431) announced a partnership with Taiwanese medical aesthetics equipment provider Juxing Medical Technology Co., Ltd. to jointly exhibit at ‘Vietbeauty & Cosmobeaut Vietnam 2026’ held in Ho Chi Minh City, Vietnam, from July 23 to 25. This collaboration integrates medical aesthetics equipment, medical-grade skincare products, and clinic services, showcasing the transformation of Taiwan’s medical aesthetics industry from single-product exports to integrated service output.

Guangli Biotechnology Chairman Wang Jiawei stated that Vietnam is a key foothold for the group’s expansion into the Southeast Asian market. He noted that the collaboration with Juxing Medical is not merely about co-exhibiting products but represents a critical starting point for integrating Taiwanese medical aesthetics equipment, biotech skincare, and local operational resources. In the future, based on the Hanoi office and leveraging Juxing Medical’s layout in Ho Chi Minh City, the group will continue to deepen local channel and clinic partnerships, gradually establishing an operational model replicable in other Southeast Asian markets.

Guangli Group has established an office in Hanoi, Vietnam, serving as a base for market development, channel negotiations, and after-sales service. The move to enter the Ho Chi Minh City beauty exhibition, together with Juxing Medical Technology, further connects the northern and southern markets of Vietnam. During the exhibition, Guangli’s booth received the ‘Sustainable Better Stands Bronze’ award from the organizer, reflecting that the booth design not only balanced brand identity and product display but also met the organizer’s criteria for material usage and sustainable exhibition concepts.

Guangli Group pointed out that this collaboration involves Guangli Group’s subsidiary, Shanghai Yidai, manufacturing the Glor au Centella Asiatica Restorative Series of medical-grade skincare products, while Juxing Medical provides medical aesthetics equipment and technical support. Together, they aim to build an integrated operational model covering ‘medical aesthetics equipment, treatment applications, professional skincare, home care, and local services.’
Additionally, Juxing’s exhibited equipment includes the E20 low-temperature plasma device, D12 IPL pulsed light device, and M10 multi-functional platform, covering low-temperature plasma, pulsed light, and multi-functional treatment platforms to meet the needs of different clinic sizes and treatment requirements. Guangli showcased professional skincare products such as the Glor au Centella Asiatica Restorative Series, presenting a complete service concept extending from in-clinic treatments to home care.